- Jefferies’ quarterly profit beats estimate as dealmaking rebound drives record advisory fees Reuters
- Jefferies’ quarterly profit beats estimate on record advisory fees, dealmaking rebound Yahoo Finance
- Jefferies Posts Record Revenue With…
Category: 6. Business
-
Jefferies' quarterly profit beats estimate as dealmaking rebound drives record advisory fees – Reuters
-
ACC CardioSurve: Improved Education, Guidelines For Clinicians Could Boost Cardiogenetic Testing
Cardiogenetic testing could be more widely implemented if clinicians had improved access to genetic counselors and professionals, clearer guidelines and expanded education, according to a survey of the ACC CardioSurve Panel and published July 7…
Continue Reading
-
PAM50 Biomarker May Predict Apalutamide Efficacy in Prostate Cancer
The addition of apalutamide (Erleada) to secondary radiotherapy (SRT) produced clinically meaningful benefits among patients with recurrent prostate cancer and luminal B tumors, supporting PAM50 as a validated biomarker that may guide the use of…
Continue Reading
-
Comparative analysis of commercial human primary mesangial cell, implications for experimental design | BMC Nephrology
Latta H. An approach to the structure and function of the glomerular Mesangium. J Am Soc Nephrol. 1992;2(10 Suppl):S65–73.
Google Scholar
Lai KN, Tang SC, Schena FP, Novak…
Continue Reading
-
AI Offers Multitude of Benefits in Community Practice, But Barriers to Implementation Remain
To efficiently integrate artificial intelligence (AI) tools into community cancer care, technical, clinical, economic, regulatory and ethical challenges must first be adequately addressed, according to Kashyap Patel MD, ABIM, BCMAS.1
“AI…
Continue Reading
-
Comparing causal inference methods for point exposures with missing confounders: a simulation study | BMC Medical Research Methodology
In order to compare the validity of various reasonable but ad hoc analytic approaches to the CCMAR-based estimators, we conduct a series of simulations. The aims of this simulation study are twofold:
-
1.
…
Continue Reading
-
1.
-
Selecting Cytotoxic Partner For Pembrolizumab in PD-L1+ TNBC | Targeted Oncology
Although HER2 and hormone therapy approaches are ineffective for patients with triple-negative breast cancer (TNBC), using immunotherapy in those with positive PD-L1 expression has been shown to improve on standard chemotherapy. In a virtual…
Continue Reading
-
DuPont to Expand FilmTec™ Manufacturing into China through Reverse Osmosis Acquisition
WILMINGTON, Del., Sept. 29, 2025 – DuPont (NYSE: DD) has signed an agreement to acquire Sinochem (Ningbo) RO Memtech Co., Ltd. (“Sinochem (Ningbo) Memtech”) to expand its reverse osmosis (RO) manufacturing footprint into China and…
Continue Reading
-
Norwegian Cruise Line Holdings Ltd. (NCLH)
Elevating recognition and rewarding brand loyalty, Norwegian Cruise Line Holdings Ltd. unlocks more ways for guests to explore the world across its three award-winning brands: Norwegian Cruise…
Continue Reading
-
Etentamig Shows Manageable Safety and Low Severe Infection Risk in RRMM | Pharmacy Times
Pooled data from 2 phase 1 trials show that etentamig (ABBV-383; AbbVie Inc) has a manageable safety profile and low incidence of grades 3 and 4 infection in patients with relapsed/refractory multiple myeloma (RRMM). The findings, presented at the…
Continue Reading